Advertisement
Advertisement
CASE STUDIES & WEBINARS

Welcome to JADPRO’s Clinical Case Series. In each of the modules below, you can read about 3 related patient cases, answer some questions to share your perspective on the topic, and then attend a live webinar to explore the cases further and get clinical pearls from our faculty experts.

New!

Considerations in the Diagnosis and Treatment of Chronic Graft-vs-Host Disease

Faculty

Erin Kopp, DNP, ACNP-BC, BMTCN

New!

BTK Inhibitor Considerations in Chronic Lymphocytic Leukemia and Waldenström Macroglobulinemia Patient Populations

Faculty

Josie Montegaard, MSN, AGPCNP-BC

Catherine Flynn, NP

New!

Second-Line CAR T-Cell Therapy for Multiple Myeloma

Faculty

Michelle Lauer, PA-C, MPH

New!

Cytopenias, Including Transfusion-Dependent Anemia, in Myelofibrosis

Faculty

Sandra E. Kurtin, PhD, ANP-C, AOCN, FAPO

New!

Bispecific Antibodies in DLBCL: Navigating the Evolving Treatment Landscape

Faculty

Jacklyn Gideon, MSN, AGNP-BC

New!

Maintaining High Quality of Life, Good Performance Status in Refractory Colorectal Cancer

Faculty

Tammy Triglianos, DNP, ANP-BC, AOCNP

New!

Understanding Patient Goals and Risk Factors When Determining Therapy for Newly Diagnosed and Recurrent/Relapsed CLL

Faculty

Sara M. Tinsley-Vance, PhD, APRN, AOCN

New!

Managing Fertility and Treatment-related Side Effects in Premenopausal Patients with Breast Cancer

Faculty

Kelley Mayden, DNP, APRN-FNP, AOCNP

New!

Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care (Part 1)

Faculty

Rebecca Lu, MSN, RN, FNP-C

New!

Management of Patients With Multiple Myeloma Receiving CAR T-Cell Therapy: Timing, Adverse Events, and Coordination of Care (Part 2)

Faculty

Rebecca Lu, MSN, RN, FNP-C

New!

To Extend or Not Extend? Evaluating the Need for Extended Endocrine Therapy in Patients With Early-Stage HR+ Breast Cancer

Faculty

Michelle Butaud, APRN, ANP, AOCNP, CBCN

New!

Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma (Part 1)

Faculty

Josh Epworth, MSN, ARNP

New!

Key Principles in Safely Prescribing Bispecific Antibodies in Heavily Pretreated Patients With Multiple Myeloma (Part 2)

Faculty

Josh Epworth, MSN, ARNP

New!

Treatment Selection and AE Management in Follicular Lymphoma

Faculty

Jennifer L. Garson, PA-C

New!

Considerations in Front-Line Treatment Selection for CLL

Faculty

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

New!

BTK Inhibitors Beyond CLL: Their Role in the Treatment of Select B-Cell Malignancies

Faculty

Laura J. Zitella, MS, RN, ACNP-BC, AOCN

New!

Case Studies in Myeloid Disorders: The Advanced Practitioner's Role in Patient Management

Faculty

Allyson Price, MPAS, PA-C

New!

Managing CLL Patients Receiving BTK Inhibitor Treatment: Considerations for Advanced Practitioners

Faculty

Jill Miller, MS, PA-C

New!

The Role of the Advanced Practitioner in Managing Painful Bone Metastases With RFA

Faculty

Jeannine M. Brant, PhD, APRN-CNS, AOCN, FAAN

If you enjoyed these Clinical Case Series modules, check back often to see more on new topics.

Let us know what you'd like to learn more about at editor@advancedpractitioner.com